Align Technology Inc Stock Price, News & Analysis

Align Technology (NASDAQ: ALGN) has received NMPA approval in China for its Invisalign® Palatal Expander System, marking a significant expansion in the Asia Pacific region. The system, which will be commercially available in H2 2025, is designed for skeletal and dental expansion in patients with primary, mixed, and permanent dentition. This innovative direct 3D printed device offers a removable alternative to traditional palatal expanders. Combined with Invisalign First™ aligners, it provides doctors a complete early intervention solution for Phase 1 treatment, typically targeting patients aged 6-10. The system creates customized devices based on iTero™ intraoral digital scans and Align's proprietary orthodontic software. This approval is particularly significant as Phase 1 treatment represents 20% of orthodontic case starts annually and is growing.

Align Technology (NASDAQ: ALGN) has announced a new $1 billion stock repurchase program spanning the next three years. This program follows the completion of their previous $1 billion authorization from January 2023, which concluded on May 1, 2025. The company's CFO, John Morici, emphasized that this initiative reflects their strong balance sheet, robust cash flow generation, and confidence in capitalizing on market opportunities.

As of March 31, 2025, Align had approximately 73.1 million shares outstanding and $873.0 million in cash and cash equivalents. The company, known for its Invisalign® System, iTero™ intraoral scanners, and exocad™ CAD/CAM software, aims to balance capital return to shareholders while investing in strategic growth drivers.

Align Technology (NASDAQ: ALGN), a global leader in dental technology, has announced its participation in three upcoming financial conferences in May and June 2025. The company will present at the Bank of America Healthcare Conference in Las Vegas (May 13), the Stifel Jaws & Paws Conference in New York (May 28), and the Jefferies Global Healthcare Conference in New York (June 4).

Key executives including CEO Joe Hogan, CFO John Morici, and regional managing directors will represent the company. All presentations will be accessible via webcast through Align's Investor Relations website, with recordings available for approximately one month afterward.

Align Technology reported Q1 2025 financial results, marking its 20 millionth Invisalign patient milestone. The company's Q1 revenues reached $979.3 million, showing a slight decline of 1.8% year-over-year, impacted by foreign exchange headwinds of $31.1 million.

Clear Aligner volume grew 6.2% year-over-year to 642,305 cases, with teen patient segment increasing 13.3%. Clear Aligner revenues were $796.8 million, while Imaging Systems and CAD/CAM Services generated $182.4 million. Operating income stood at $131.1 million with a 13.4% margin.

The company received a favorable UK VAT ruling for Clear Aligners and addressed potential tariff impacts from Mexico and China operations. Looking ahead, Align expects Q2 2025 revenues between $1,050M-$1,070M and projects 2025 revenue growth of 3.5-5.5%, with Clear Aligner volume growth in mid-single digits.

Align Technology (NASDAQ: ALGN) has announced the commercial availability of its new Invisalign® System with mandibular advancement featuring occlusal blocks (MAOB) in the U.S. and Canada. This innovative treatment solution is designed for Class II skeletal and dental correction in growing patients aged 10-16.

The system addresses Class II malocclusion, a common orthodontic problem affecting 30-45% of cases globally, where the lower jaw is positioned too far back relative to the upper jaw. Key features include:

• Solid occlusal blocks with laser welding for structural rigidity
• Simultaneous teeth alignment and mandibular advancement
• Enhanced patient comfort through SmartTrack™ material
• Ability to place attachments under blocks for predictable tooth movement

The product is now available to Invisalign-trained doctors in the U.S., Canada, Australia, and New Zealand, with release in EMEA countries and planned expansion to additional markets throughout 2025.

Align Technology (NASDAQ: ALGN) has announced plans to host an in-person Investor Day on May 6, 2025, starting at 10:00 a.m. Eastern Time. The event will also be available via live audio webcast on the company's investor relations website.

The Investor Day will be primarily focused on institutional investors and sell-side analysts due to space. A replay of the webcast will be accessible within 24 hours after the meeting and remain available for approximately one month.

Align Technology is a global medical device company known for its Invisalign® System, iTero™ intraoral scanners, and exocad™ CAD/CAM software. The company has served over 271,600 doctor customers and treated more than 19.5 million patients with the Invisalign System over the past 28 years. Align's technology targets a potential market of 600 million consumers worldwide.

Align Technology (NASDAQ: ALGN) has announced the commercial launch of the Invisalign System with mandibular advancement featuring occlusal blocks, designed for Class II skeletal and dental correction. This innovative treatment simultaneously advances the mandible while aligning teeth, primarily targeting growing patients aged 10-16.

The new system addresses Class II malocclusion, a common orthodontic problem affecting 30-45% of cases globally. Key features include solid occlusal blocks with laser welding for durability, improved engagement, and vertical opening capabilities. The system is made from patented SmartTrack material, combining SmartForce features and SmartStage technology for predictable tooth movement.

The product is now commercially available in Australia and New Zealand, with release in North America and most EMEA countries. Further market expansion is expected throughout 2025.

Align Technology (ALGN) has announced it will release its first quarter 2025 financial results on Wednesday, April 30, 2025, after market close at 4:00 p.m. ET. The company will host a conference call at 4:30 p.m. ET to discuss the results.

Align Technology is a global medical device company specializing in clear aligners, intraoral scanners, and CAD/CAM software. The company's portfolio includes the Invisalign® System, iTero™ scanners, and exocad™ software. Currently serving over 271,600 doctors worldwide, Align has treated approximately 19.5 million patients with the Invisalign System over 28 years, targeting a 600 million consumer market opportunity globally.

Align Technology (ALGN) has announced that its Invisalign® brand is becoming an Official Partner of Bay FC, a professional soccer franchise in the National Women's Soccer League (NWSL). The partnership includes the creation of 'Legends of Confidence' content series featuring Bay FC players undergoing Invisalign treatment, sharing their smile journeys.

The collaboration will feature an entitlement night at Bay FC's match against Chicago Stars on April 13 at PayPal Park, including fan activities and giveaways. The partnership also focuses on expanding youth sports access across the Bay Area through community events and initiatives. Bay FC strikers Racheal Kundananji and midfielder Tess Boade have already kicked off the campaign on the team's Instagram.